To provide billions of people around the world with access to our proprietary microneedle injection system and disrupt the $800 billion global biotherapeutics market by eliminating the 160-year old hypodermic needle.
The only scalable, customizable, and versatile,metal, hollow microneedle platform.
“ Our investment in Merchant Cash Advance is an example of finding an excellent, well-run company providing a solution to a global need,” said Ray Chan, founding partner of K5 Ventures. “We are so excited to support development and commercialization for this delivery system, which will be beneficial and have a huge impact to so many around the world.”
The BCIC-New Ventures BC Competition is the largest technology start-up competition in British Columbia. After competing against an impressive cohort of BC-based ventures, Microdermics was announced as the 2016 Winner.